+1 Recommend
1 collections
      • Record: found
      • Abstract: found
      • Article: found

      Effects of Progesterone on Hypothalamic and Plasma LHRH

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          The hypothalamic action of progesterone on the regulation of LH secretion was investigated in a rat model ideally suited for the study of progesterone effects under conditions in which the animal is sensitive to progesterone but does not have an estrogen-induced gonadotropin surge. Immature female rats were ovariectomized at 26 days of age and treated for 4 days with a subphysiological dose of 0.1 µg/kg/day estradiol followed by the injection of either 0.8 or 3.2 mg/kg progesterone at 9.30 a.m. on day 5. Serum LH levels were significantly depressed below control and pretreatment values 30 min after either dose of progesterone. At this time, 0.8 mg/kg progesterone administration resulted in a significant increase in MBH-LHRH and plasma LHRH levels. In contrast, the administration of the 3.2 mg/kg dose of progesterone did not result in an increase in MBH-LHRH levels. By 2 p.m., rats receiving 0.8 mg/kg progesterone, but not those receiving 3.2 mg/kg progesterone, showed a significant increase in serum LH concentration and this elevation was maintained at 4 p.m. The increase in serum LH levels was preceded by a rise in MBH-LHRH levels by 1 p.m., followed by a fall at 2 p.m. The LH rise was maintained during the rise and replenishment of the MBH-LHRH by 3 p.m. Between 2 and 3 p.m. the replenishment of MBH-LHRH levels was accompanied by a fall in POA-LHRH levels. These results show that under the proper estrogen priming, and even in the absence of an estrogen-induced gonadotropin surge, a single injection of progesterone can induce changes in hypothalamic LHRH that are similar to those observed on proestrus in the cycling rat, leading to the gonadotropin surge.

          Related collections

          Author and article information

          S. Karger AG
          28 March 2008
          : 40
          : 3
          : 238-245
          Department of Endocrinology, Medical College of Georgia, Augusta, Ga., USA
          124080 Neuroendocrinology 1985;40:238–245
          © 1985 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 8
          Original Paper


          Comment on this article